T1	Participants 98 120	ventricular arrhythmia
T2	Participants 177 229	18 adult patients (7 women and 11 men) aged 50 +/- 7
T3	Participants 947 1050	Three patients dropped out of the trial, 1 with each active drug (for epigastric pain) and 1 with dummy
T4	Participants 2064 2115	population with a low risk of serious rhythm events
